XyloCor Therapeutics
Howard Dittrich, MD, is a cardiologist Adjunct Professor of Medicine, and Chair of the Board of Directors of the François M. Abboud Cardiovascular Research Center at the University of Iowa Carver College of Medicine. He is the former CMO at Cirius Therapeutics and other biotech companies including NovaCardia, Sequel, and Laguna. Dr. Dittrich has extensive experience in regenerative medicine for CV disease.
This person is not in any offices
XyloCor Therapeutics
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.